| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
4,738 |
2,037 |
$720K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,420 |
3,046 |
$200K |
| 99233 |
Prolong inpt eval add15 m |
1,403 |
790 |
$80K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
940 |
829 |
$36K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
167 |
161 |
$19K |
| 99205 |
Prolong outpt/office vis |
73 |
66 |
$9K |
| 94729 |
|
309 |
276 |
$6K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
147 |
88 |
$6K |
| 94726 |
|
97 |
91 |
$2K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
28 |
24 |
$2K |
| 94060 |
|
108 |
93 |
$2K |
| 99215 |
Prolong outpt/office vis |
30 |
25 |
$1K |
| 95811 |
|
14 |
12 |
$1K |
| 95806 |
|
12 |
12 |
$749.68 |
| 99406 |
|
71 |
64 |
$596.76 |
| 88738 |
|
53 |
41 |
$122.56 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
3,382 |
3,153 |
$0.00 |
| 4040F |
|
1,392 |
1,291 |
$0.00 |
| 1124F |
|
1,187 |
1,150 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
1,749 |
1,626 |
$0.00 |
| 3023F |
|
68 |
67 |
$0.00 |
| G8855 |
Adherence to therapy was not assessed at least annually through an objective informatics system or through self-reporting (if objective reporting is not available), reason not given |
16 |
16 |
$0.00 |
| 99072 |
|
170 |
152 |
$0.00 |
| 4025F |
|
13 |
13 |
$0.00 |
| 98960 |
|
19 |
17 |
$0.00 |
| 1036F |
|
528 |
515 |
$0.00 |
| G8734 |
Elder maltreatment screen documented as negative, follow-up is not required |
251 |
227 |
$0.00 |
| 1123F |
|
844 |
775 |
$0.00 |
| G8924 |
Spirometry results documented (fev1/fvc < 70%) |
85 |
85 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
15 |
12 |
$0.00 |